Evidence map›Paper›PMID 32719914›Full record

ReviewEuropean journal of nuclear medicine and molecular imaging2021

Hybrid PET/MRI in non-small cell lung cancer (NSCLC) and lung nodules-a literature review.

Sara E Dahlsgaard-Wallenius, Malene Grubbe Hildebrandt, Allan Johansen, Mie Holm Vilstrup, Henrik Petersen, Oke Gerke, Poul Flemming Høilund-Carlsen, Anni Morsing, Thomas Lund Andersen

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Diagnostic performance of whole-body [European radiology · 2024
    Pooled it
  3. Diagnostic potential of [Japanese journal of radiology · 2024
    Pooled it
  4. [Frontiers in medicine · 2024
    Pooled it
  5. Diagnostic impact of 18F-FDG PET/MRI over PET/CT in histiocytoses: a prospective comparative study.European journal of nuclear medicine and molecular imaging · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. [European journal of nuclear medicine and molecular imaging · 2023
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. PET/MRI Improves Management of Children with Cancer.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Review
  19. Diagnostic efficiency of whole-bodyCancer imaging : the official publication of the International Cancer Imaging Society · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sara E Dahlsgaard-WalleniusDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark. sarawallenius@hotmail.com.ORCID 0000-0003-1271-8784
Malene Grubbe HildebrandtDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Allan JohansenDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Mie Holm VilstrupDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Henrik PetersenDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Oke GerkeDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Poul Flemming Høilund-CarlsenDepartment of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Anni Morsing *MAgNetic resonance Technology for Response Adapted radiotherapy (MANTRA), Odense University Hospital, Odense, Denmark.
Thomas Lund Andersen *Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Odense University Hospital · DKUniversity of Southern Denmark · DKNovo Nordisk (Denmark) · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of hybrid PET/MRI for clinical staging is growing in several cancer forms and, consequently, PET/MRI has also gained interest in the assessment of non-small cell lung cancer (NSCLC) and lung lesions. However, lung evaluation with PET/MRI is associated with challenges related to technical issues and diagnostic image quality. We, therefore, investigated the published literature on PET/MRI for clinical staging in NSCLC or lung nodule detection specifically addressing diagnostic accuracy and technical issues.

methodsThe data originates from a systematic search performed in PubMed/MEDLINE, Embase, and Cochrane Library on hybrid PET/MRI in patients with cancer for a scoping review published earlier ( https://doi.org/10.1007/s00259-019-04402-8 ). Studies in English and German evaluating the diagnostic performance of hybrid PET/MRI for NSCLC or lung nodule detection in cancer patients were selected. Data reported in peer-reviewed journals without restrictions to year of publication were included.

resultsA total of 3138 publications were identified from which 116 published 2012-2018 were included. Of these, nine studies addressed PET/MRI in NSCLC (4) or lung nodule detection (5). Overall, PET/MRI did not provide advantages in preoperative T- and N-staging in NSCLC compared to PET/CT. The data on M-staging were too few for conclusions to be drawn. The lung nodule detection rate of PET/MRI was comparable to that of PET/CT for FDG-avid nodules larger than 10 mm, but the sensitivity of PET/MRI for detection of non-FDG-avid nodules smaller than 5 mm was low.

conclusionPET/MRI did not provide advantages in T- and N-staging of NSCLC compared to PET/CT. PET/MRI had a comparable sensitivity for detection of FDG-avid lung nodules and nodules over 10 mm, but PET/CT yielded a higher detection rate in non FDG-avid lung nodules under 5 mm. With PET/MRI, the overall detection rate for lung nodules in various cancer types remains inferior to that of PET/CT due to the lower diagnostic performance of MRI than CT in the lungs.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsFluorodeoxyglucose F18HumansLungMagnetic Resonance ImagingNeoplasm StagingPositron-Emission TomographyPositron Emission Tomography Computed TomographySensitivity and SpecificityTomography, X-Ray ComputedFluorodeoxyglucose F1818F-FDGLung lesionsNSCLCPET/CTPET/MRI

Identifiers

PMID32719914
OpenAlexW3046003797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.